tiprankstipranks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
HKEX:3692
Hong Kong Market
Holding HK:3692?
Track your performance easily

Hansoh Pharmaceutical Group Company Limited (3692) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

3692 Analyst Ratings

Strong Buy
5Ratings
4 Buy
1 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Hansoh
Pharmaceutical Group Company Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

3692 Stock 12 Month Forecast

Average Price Target

HK$24.61
▲(37.79% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Hansoh Pharmaceutical Group Company Limited in the last 3 months. The average price target is HK$24.61 with a high forecast of HK$30.00 and a low forecast of HK$17.95. The average price target represents a 37.79% change from the last price of HK$17.86.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"HK$12","31":"HK$31","16.75":"HK$16.75","21.5":"HK$21.5","26.25":"HK$26.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$24.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$17.95</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,16.75,21.5,26.25,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Nov<br/>2024","25":"Nov<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.84,18.775384615384617,19.71076923076923,20.646153846153847,21.58153846153846,22.516923076923078,23.45230769230769,24.38769230769231,25.323076923076922,26.25846153846154,27.193846153846152,28.12923076923077,29.064615384615387,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.84,18.36076923076923,18.88153846153846,19.40230769230769,19.923076923076923,20.443846153846152,20.964615384615385,21.485384615384614,22.006153846153847,22.526923076923076,23.04769230769231,23.568461538461538,24.089230769230767,{"y":24.61,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.84,17.84846153846154,17.856923076923078,17.865384615384617,17.873846153846152,17.88230769230769,17.89076923076923,17.89923076923077,17.907692307692308,17.916153846153847,17.924615384615382,17.93307692307692,17.94153846153846,{"y":17.95,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.38,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":14.41,"date":1700179200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.59,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.67,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.04,"date":1710460800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":15.57,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.91,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.5,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.47,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.47,"date":1722556800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.68,"date":1725580800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.6,"date":1728000000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.84,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$30.00Average Price TargetHK$24.61Lowest Price TargetHK$17.95
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities
HK$16.4HK$20.8
Buy
16.46%
Upside
Upgraded
06/07/24
BofA Securities Upgrades Hansoh Pharma (3692:HK) (HNSPF) to BuyBofA Securities analyst David Li upgraded Hansoh Pharma (3692:HK) (OTC: HNSPF) from Underperform to Buy with a price target of HK$20.80 (from HK$16.40).
HSBC
HK$18.5HK$18.6
Buy
4.14%
Upside
Reiterated
04/02/24
Hansoh Pharma (3692:HK) (HNSPF) PT Raised to HK$18.60 at HSBCHSBC analyst Linda Shu raised the price target on Hansoh Pharma (3692:HK) (OTC: HNSPF) to HK$18.60 (from HK$18.50) while maintaining a Buy rating.
CLSA Analyst forecast on HK:3692
Unknown Analyst
Not Ranked
CLSA
HK$13.7HK$19.2
Buy
7.50%
Upside
Reiterated
04/04/24
Hansoh Pharma (3692:HK) (HNSPF) PT Raised to HK$19.20 at CLSACLSA analyst John Yung raised the price target on Hansoh Pharma (3692:HK) (OTC: HNSPF) to HK$19.20 (from HK$13.70) while maintaining a Buy (1) rating.

Best Analysts Covering Hansoh Pharmaceutical Group Company Limited

Which Analyst Should I Follow If I Want to Buy HK:3692 and Sell After:
1 Month
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+20.87%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +20.87% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
67%
Average Return
+15.53%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +15.53% per trade.
1 Year
Success Rate
3/3 ratings generated profit
100%
Average Return
+62.47%
reiterated a buy rating 8 months ago
Copying Linda Shu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +62.47% per trade.
2 Years
xxx
Success Rate
3/3 ratings generated profit
100%
Average Return
+42.70%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +42.70% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

3692 Analyst Recommendation Trends

Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
0
0
0
0
0
Buy
3
3
4
4
7
Hold
1
1
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
6
6
8
In the current month, 3692 has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 3692 average Analyst price target in the past 3 months is HK$24.61.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

3692 Financial Forecast

3692 Earnings Forecast

Next quarter’s earnings estimate for 3692 is HK$0.24 with a range of HK$0.24 to HK$0.24. The previous quarter’s EPS was HK$0.49. 3692 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.47% of the time in the same period. In the last calendar year 3692 has Outperformed its overall industry.
Next quarter’s earnings estimate for 3692 is HK$0.24 with a range of HK$0.24 to HK$0.24. The previous quarter’s EPS was HK$0.49. 3692 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.47% of the time in the same period. In the last calendar year 3692 has Outperformed its overall industry.

3692 Sales Forecast

Next quarter’s sales forecast for 3692 is HK$5.77B with a range of HK$5.77B to HK$5.77B. The previous quarter’s sales results were HK$7.05B. 3692 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 51.03% of the time in the same period. In the last calendar year 3692 has Outperformed its overall industry.
Next quarter’s sales forecast for 3692 is HK$5.77B with a range of HK$5.77B to HK$5.77B. The previous quarter’s sales results were HK$7.05B. 3692 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 51.03% of the time in the same period. In the last calendar year 3692 has Outperformed its overall industry.

3692 Stock Forecast FAQ

What is HK:3692’s average 12-month price target, according to analysts?
Based on analyst ratings, Hansoh Pharmaceutical Group Company Limited’s 12-month average price target is HK$24.61.
    What is HK:3692’s upside potential, based on the analysts’ average price target?
    Hansoh Pharmaceutical Group Company Limited has 37.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Hansoh Pharmaceutical Group Company Limited a Buy, Sell or Hold?
          Hansoh Pharmaceutical Group Company Limited has a consensus rating of Strong Buy, which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Hansoh Pharmaceutical Group Company Limited’s share price target?
            The average share price target for Hansoh Pharmaceutical Group Company Limited is HK$24.61. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$30.00 ,and the lowest forecast is HK$17.95. The average share price target represents 37.79% Increase from the current price of HK$17.86.
              What do analysts say about Hansoh Pharmaceutical Group Company Limited?
              Hansoh Pharmaceutical Group Company Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Hansoh Pharmaceutical Group Company Limited?
                To buy shares of HK:3692, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis